Table 2. Demographic and clinical characteristics of children with tungiasis (n = 50).
| Characteristic | N (%) | ||
| total | Male | Female | |
| Sex | 50 (100) | 35 (70) | 15 (30) |
| Age (years) | |||
| Median | 8 | 9 | 8 |
| Range | 5–14 | 5–14 | 5–14 |
| Clinical pathology | N (%) | ||
| Erythema/warmness/oedema | 43 (86) | 29 (83) | 14 (93) |
| Suppuration/ulcer/abscess | 27 (54) | 21 (60) | 6 (40) |
| Local pain (points)* | |||
| 0 | 6 (12) | 4 (11) | 2 (13) |
| 1 | 19 (38) | 11 (31) | 8 (53) |
| 2 | 15 (30) | 11 (31) | 4 (27) |
| 3 | 10 (20) | 9 (26) | 1 (7) |
| Itching (points)* | |||
| 0 | 3 (6) | 2 (6) | 1 (7) |
| 1 | 32 (64) | 22 (63) | 10 (67) |
| 2 | 9 (18) | 6 (17) | 3 (20) |
| 3 | 6 (12) | 5 (14) | 1 (7) |
| Number of lesions | Median (IQR) | ||
| All lesions types | 52.5 (40–81.5) | 59 (41.5–85.5) | 43 (27–75) |
| Viable lesions | 7 (3–12.75) | 8 (4–15.5) | 4 (1–7.5) |
| Non-viable lesions | 12.5 (6–19.8) | 13 (6.5–13) | 9 (4.5–18.5) |
| Manipulated lesions | 33 (25–48.75) | 37 (26–50) | 31 (14–48) |
| Severity scores | Median (IQR) | ||
| SSAT | 10 (7.25–12) | 10 (8–14.5) | 8 (7–10.5) |
| SSCT | 6 (4–7.5) | 6.5 (4–8) | 6 (4.5–6) |
* indicated by the patient using a visual scale; see Material and methods
IQR: interquartile range
SSAT: severity score for acute tungiasis
SSCT: severity score for chronic tungiasis